We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

180 hedge funds and large institutions have $973M invested in Cogent Biosciences in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 79 increasing their positions, 36 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more call options, than puts

Call options by funds: $20.5M | Put options by funds: $6.52M

119% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 36

22% more capital invested

Capital invested by funds: $800M → $973M (+$174M)

13% more funds holding in top 10

Funds holding in top 10: 8 → 9 (+1)

1.79% more ownership

Funds ownership: 117.25% → 119.04% (+1.8%)

3% less funds holding

Funds holding: 186 → 180 (-6)

14% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 35

Holders
180
Holders Change
-6
Holders Change %
-3.23%
% of All Funds
2.37%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.12%
New
30
Increased
79
Reduced
36
Closed
35
Calls
$20.5M
Puts
$6.52M
Net Calls
+$13.9M
Net Calls Change
+$15M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$15.8M
2
EA
Emerald Advisers
Pennsylvania
+$8.01M
3
PBA
Paradigm Biocapital Advisors
New York
+$7.7M
4
IC
Ikarian Capital
Texas
+$5.74M
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$4.96M

Top Sellers

Rank Fund Capital Flow
1
CC
Commodore Capital
New York
-$36.5M
2
RG
Redmile Group
California
-$9.8M
3
Franklin Resources
Franklin Resources
California
-$7.95M
4
SG Americas Securities
SG Americas Securities
New York
-$5.68M
5
VA
VR Adviser
New York
-$5.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
201
IEQ Capital
California
– -$101K -16,792 Closed
FGP
202
Freestone Grove Partners
California
– -$98.9K -16,511 Closed
FA
203
Forefront Analytics
Pennsylvania
– -$83.5K -14,015 Closed
HSBC Holdings
204
HSBC Holdings
United Kingdom
– -$63K -10,604 Closed
SSA
205
Schonfeld Strategic Advisors
New York
– -$60.4K -10,080 Closed
ACM
206
Aster Capital Management
United Arab Emirates
– -$15.5K -2,061 Closed
SW
207
SVB Wealth
Massachusetts
– -$3.23K -539 Closed
TWD
208
True Wealth Design
Ohio
– -$1.66K -277 Closed
Amundi
209
Amundi
France
– -$656 -123 Closed
APW
210
Aventura Private Wealth
Florida
– -$671 -112 Closed
FFO
211
Fortitude Family Office
Arizona
– -$629 -105 Closed
SC
212
Stephens Consulting
Michigan
– -$360 -60 Closed
LFG
213
Larson Financial Group
Missouri
– -$96 -16 Closed
C
214
Covestor
United Kingdom
– +$39 +7 +64%
5 6 7 8
9

COGT Hedge Fund Activity: Q2 2025 in Review

180 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q2 2025, worth a combined $973M — up 22% from $800M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of COGT and 30 opened new positions — a net loss of 5 holders — while 36 trimmed existing stakes and 79 added.

The largest buyer was Janus Henderson Group, adding an estimated $15.8M. The largest seller was Commodore Capital, cutting an estimated $36.5M.

  • 180 institutional investors held Cogent Biosciences (COGT) as of Q2 2025, down from 186 in Q1 2025.
  • Funds reported $973M of Cogent Biosciences stock for Q2 2025, up 22% quarter-over-quarter.
  • 30 funds opened new Cogent Biosciences positions in Q2 2025 and 35 closed out, a net change of -5 holders.
  • The largest Cogent Biosciences buyer in Q2 2025 was Janus Henderson Group, an estimated $15.8M added.
  • The largest Cogent Biosciences seller in Q2 2025 was Commodore Capital, an estimated $36.5M sold.

Based on aggregated 13F filings for Q2 2025.